AAAAAA
Results: 26-42/42
Authors:
Fenski, R
Flesch, K
Serve, S
Mizuki, M
Oelmann, E
Kratz-Albers, K
Kienast, J
Leo, R
Schwartz, S
Berdel, WE
Serve, H
Citation: R. Fenski et al., Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells, BR J HAEM, 108(2), 2000, pp. 322-330
Authors:
Padro, T
Berdel, WE
Buchner, T
Mesters, RM
Citation: T. Padro et al., Angiogenesis and prognosis in acute myeloid leukemia - Response, BLOOD, 96(4), 2000, pp. 1617-1618
Authors:
Muller, C
Yang, R
Park, DJ
Serve, H
Berdel, WE
Koeffler, HP
Citation: C. Muller et al., The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin Al in acute promyelocytic leukemia, BLOOD, 96(12), 2000, pp. 3894-3899
Authors:
Mizuki, M
Fenski, R
Halfter, H
Matsumura, I
Schmidt, R
Muller, C
Gruning, R
Kratz-Abers, K
Serve, S
Steur, C
Buchner, T
Kienast, J
Kanakura, Y
Berdel, WE
Serve, H
Citation: M. Mizuki et al., Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways, BLOOD, 96(12), 2000, pp. 3907-3914
Authors:
Padro, T
Berdel, WE
Buchner, T
Mesters, RM
Citation: T. Padro et al., Angiogenesis and anemia in acute myeloid leukemia, BLOOD, 96(10), 2000, pp. 3656-3657
Authors:
Dankbar, B
Padro, T
Leo, R
Feldmann, B
Kropff, M
Mesters, RM
Serve, H
Berdel, WE
Kienast, J
Citation: B. Dankbar et al., Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma, BLOOD, 95(8), 2000, pp. 2630-2636
Authors:
Mohr, M
Hilgenfeld, E
Fietz, T
Hoppe, B
Koenigsmann, M
Hoffmann, M
Knauf, WU
Cassens, U
Sibrowski, W
Kienast, J
Thiel, E
Berdel, WE
Citation: M. Mohr et al., Efficacy and safety of simultaneous immunomagnetic CD34+cell selection andbreast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy, CLIN CANC R, 5(5), 1999, pp. 1035-1040
Authors:
Serve, H
Flesch, K
Serve, S
Fenski, R
Berdel, WE
Citation: H. Serve et al., Expression and function of Flt3/flk2 in human tumor cell lines, INT J ONCOL, 14(4), 1999, pp. 765-770
Authors:
Thomas, M
Rube, C
Semik, M
von Eiff, M
Klinke, F
Macha, HN
Freitag, L
Scheld, HH
Willich, N
Berdel, WE
Junker, K
Citation: M. Thomas et al., Trimodality therapy in stage III non-small cell lung cancer: prediction ofrecurrence by assessment of p185(neu), EUR RESP J, 13(2), 1999, pp. 424-429
Authors:
Thomas, M
Rube, C
Semik, M
von Eiff, M
Freitag, L
Macha, HN
Wagner, W
Klinke, F
Scheld, HH
Willich, N
Berdel, WE
Junker, K
Citation: M. Thomas et al., Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer, J CL ONCOL, 17(4), 1999, pp. 1185-1193
Authors:
Hoppe, B
Mohr, M
Roots-Weiss, A
Kienast, J
Berdel, WE
Citation: B. Hoppe et al., Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells, BONE MAR TR, 23(8), 1999, pp. 809-817
Authors:
Fietz, T
Berdel, WE
Rieder, H
Reufi, B
Hopp, H
Thiel, E
Knauf, WU
Citation: T. Fietz et al., Culturing human umbilical cord blood: a comparison of mononuclear vs CD34(+) selected cells, BONE MAR TR, 23(11), 1999, pp. 1109-1115
Authors:
Steins, MB
Padro, T
Li, CX
Mesters, RM
Ostermann, H
Hammel, D
Scheld, HH
Berdel, WE
Kienast, J
Citation: Mb. Steins et al., Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries, ATHEROSCLER, 145(1), 1999, pp. 173-180
Authors:
Mross, K
Berdel, WE
Fiebig, HH
Velagapudi, R
von Broen, IM
Unger, C
Citation: K. Mross et al., Clinical and pharmacologic phase I study of Cemadotin-HCl (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer, ANN ONCOL, 9(12), 1998, pp. 1323-1330
Authors:
Koenigsmann, MP
Koenigsmann, M
Notter, M
Neuloh, M
Mucke, C
Thiel, E
Berdel, WE
Citation: Mp. Koenigsmann et al., Adhesion molecules on peripheral blood-derived CD34(+) cells: effects of cryopreservation and short-term ex vivo incubation with serum and cytokines, BONE MAR TR, 22(11), 1998, pp. 1077-1085
Authors:
Rassmann, I
Thodtmann, R
Mross, M
Huttmann, A
Berdel, WE
Manegold, C
Fiebig, HH
Kaeser-Frohlich, A
Burk, K
Hanauske, AR
Citation: I. Rassmann et al., Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion, INV NEW DR, 16(4), 1998, pp. 319-324
Authors:
Bokemeyer, C
Harstrick, A
Beyer, J
Metzner, B
Ruther, U
Hartmann, JT
Holstein, K
Derig, HG
De Wit, R
Casper, J
Schoffski, P
Kuhrer, I
Illiger, HJ
Kempf, B
Reichle, A
Foller, A
Hossfeld, DK
Fischer, JT
Berdel, WE
Gerhartz, HH
Kirchner, H
Pfluger, KH
Ostermann, H
Kanz, L
Schmoll, HJ
Citation: C. Bokemeyer et al., The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors, EUROCANCER 98, 1998, pp. 321-323